Clinical use of mean platelet volume and neutrophil-to-lymphocyte ratio to predict prognosis in heart failure with preserved ejection fraction patients

26 August 2022 (11:15 - 12:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Nassiba Menghoum

Cliniques Saint-Luc UCL, Brussels (Belgium)

8 More presentations in this session

Presentation thumbnail

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

Doctor K. Berge (Nordbyhagen, NO)

Abstract Slides

Presentation thumbnail

Introduction of a new scoring tool to identify clinically stable heart failure patients

Mr A. Gingele (Maastricht, NL)

Abstract Slides

Presentation thumbnail

Prognostic value of liver damage assessed by direct bilirubin and skeletal muscle weakness in patients with heart failure

Mr T. Noda (Suita, JP)

Abstract Slides

Presentation thumbnail

A comprehensive study of the incremental prognostic value of novel biomarkers in PARADIGM-HF (Bio-PREDICT-HF)

Doctor K. McDowell (Glasgow, GB)

Abstract Slides

Presentation thumbnail

Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials

Doctor C. Adamson (Larbert, GB)

Abstract Slides

Access the full session

Session thumbnail

Chronic heart failure - Prognosis and prediction of outcome

The Event

Event poster

ESC Congress 2022

26 August 2022 11:15 CET

You may be interested in

Congress Session

Clinical phenotypes of heart failure with preserved ejection fraction

Webinar

Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction

Webinar

Acute heart failure in patients with preserved ejection fraction (AHFPEF)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources